Fred Bergman Healthcarerequest and information pack Information Pack SimPAD Trial

SimPAD®

SimPAD® is worn by residents of aged care facilities and other sufferers of incontinence.
SimPAD® system remotely monitors their continence events; thereby assisting carers in the assessment and management of continence, and helping them deliver higher quality care to its sufferers.

How SimPAD® works
How SimPad Works
The innovation offered by the SimPAD® derives from the software. It incorporates an algorithm for automating the process of analysing signals from the sensor; interpreting the data to give an accurate assessment of the continence event; and then alerting the carer.

SimPAD® Components

Monitoring Monitoring

Key Benefits

Other Benefits

The Future of SimPAD®

This product has recently been evaluated as part of DoHA sponsored clinical trial. Preliminary results are overwhelmingly positive.

The SimPAD® is currently registered with the Therapeutic Goods Administration (TGA) as a Class 1 medical device.

The commercial product, due to be released in early 2009, will be directed at continence assessment in residential aged care. The system will include a support and training program for care staff; and allow integration with products supplied by third parties, such as continence pads, care management software and wireless networks.

The SimPAD® is also being adapted for applications in the home and in sub-acute care, for the infants, the disabled as well as the elderly. This will include products to be used as a means of evaluating treatments, and for day-to-day management of the incontinence.

More detailed technical information is available on request: Request an information pack.